Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells
David R. Withers(University of Birmingham), Matthew R. Hepworth(Cornell University), Xinxin Wang(Cornell University), Emma C. Mackley(University of Birmingham), Emily E. Halford(University of Birmingham), Emma E. Dutton(University of Birmingham), Clare Marriott(University of Birmingham), Verena Brucklacher-Waldert(Babraham Institute), Marc Veldhoen(Babraham Institute), Judith R. Kelsen(Children's Hospital of Philadelphia), Robert N. Baldassano(Children's Hospital of Philadelphia), Gregory F. Sonnenberg(Cornell University)
Cited by 245Open Access